A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease

Timothy D. Lyon, Igor Frank, Vidit Sharma, Paras H. Shah, Matthew K. Tollefson, R. Houston Thompson, R. Jeffrey Karnes, Prabin Thapa, John C. Cheville, Stephen A. Boorjian

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease'. Together they form a unique fingerprint.

Medicine & Life Sciences